Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer

Inti Zlobec, Russell Steele, René P. Michel, Carolyn Compton, Alessandro Lugli, Jeremy R. Jass

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Molecular tumor markers are often studied in colorectal cancer using immunohistochemistry to determine their prognostic or predictive value. Protein expression is typically assigned a 'positive' score based on a predetermined cutoff. A semiquantitative scoring method that evaluates the percentage of positive tumor cells (0-100%) may provide a better understanding of the prognostic or predictive significance of these markers. The aim of this study was to assess and compare the interobserver agreement of immunohistochemistry scores using a percentage scoring method and three categorical scoring systems. Immunohistochemistry for p53, Bcl-2, vascular endothelial growth factor (VEGF) and apoptotic protease activating factor-1 (APAF-1) was performed on 87 tumor biopsies from patients with rectal carcinoma and scored independently by four pathologists as the percentage of positive tumor cells. Interobserver agreement was assessed by the intraclass correlation coefficient. The intraclass correlation coefficients for p53 and VEGF (>0.6) indicate substantial agreement between observers. The distribution of Bcl-2 and APAF-1 scores in addition to weaker interobserver agreement by percentage scoring suggest that this approach may not be appropriate for these proteins. In conclusion, p53 and VEGF protein expression assessed by immunohistochemistry in colorectal cancer and scored as a percentage of positive tumor cells may be a viable alternative scoring method.

Original languageEnglish (US)
Pages (from-to)1236-1242
Number of pages7
JournalModern Pathology
Volume19
Issue number9
DOIs
StatePublished - Sep 2 2006
Externally publishedYes

Fingerprint

Apoptotic Protease-Activating Factor 1
Vascular Endothelial Growth Factor A
Colorectal Neoplasms
Immunohistochemistry
Research Design
Neoplasms
Proteins
Tumor Biomarkers
Carcinoma
Biopsy

Keywords

  • Immunohistochemistry
  • Interobserver reliability
  • p53
  • Rectal cancer
  • Scoring system
  • VEGF

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. / Zlobec, Inti; Steele, Russell; Michel, René P.; Compton, Carolyn; Lugli, Alessandro; Jass, Jeremy R.

In: Modern Pathology, Vol. 19, No. 9, 02.09.2006, p. 1236-1242.

Research output: Contribution to journalArticle

Zlobec, Inti ; Steele, Russell ; Michel, René P. ; Compton, Carolyn ; Lugli, Alessandro ; Jass, Jeremy R. / Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. In: Modern Pathology. 2006 ; Vol. 19, No. 9. pp. 1236-1242.
@article{8c9beb8e0eb740958100e5d3e99937a9,
title = "Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer",
abstract = "Molecular tumor markers are often studied in colorectal cancer using immunohistochemistry to determine their prognostic or predictive value. Protein expression is typically assigned a 'positive' score based on a predetermined cutoff. A semiquantitative scoring method that evaluates the percentage of positive tumor cells (0-100{\%}) may provide a better understanding of the prognostic or predictive significance of these markers. The aim of this study was to assess and compare the interobserver agreement of immunohistochemistry scores using a percentage scoring method and three categorical scoring systems. Immunohistochemistry for p53, Bcl-2, vascular endothelial growth factor (VEGF) and apoptotic protease activating factor-1 (APAF-1) was performed on 87 tumor biopsies from patients with rectal carcinoma and scored independently by four pathologists as the percentage of positive tumor cells. Interobserver agreement was assessed by the intraclass correlation coefficient. The intraclass correlation coefficients for p53 and VEGF (>0.6) indicate substantial agreement between observers. The distribution of Bcl-2 and APAF-1 scores in addition to weaker interobserver agreement by percentage scoring suggest that this approach may not be appropriate for these proteins. In conclusion, p53 and VEGF protein expression assessed by immunohistochemistry in colorectal cancer and scored as a percentage of positive tumor cells may be a viable alternative scoring method.",
keywords = "Immunohistochemistry, Interobserver reliability, p53, Rectal cancer, Scoring system, VEGF",
author = "Inti Zlobec and Russell Steele and Michel, {Ren{\'e} P.} and Carolyn Compton and Alessandro Lugli and Jass, {Jeremy R.}",
year = "2006",
month = "9",
day = "2",
doi = "10.1038/modpathol.3800642",
language = "English (US)",
volume = "19",
pages = "1236--1242",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer

AU - Zlobec, Inti

AU - Steele, Russell

AU - Michel, René P.

AU - Compton, Carolyn

AU - Lugli, Alessandro

AU - Jass, Jeremy R.

PY - 2006/9/2

Y1 - 2006/9/2

N2 - Molecular tumor markers are often studied in colorectal cancer using immunohistochemistry to determine their prognostic or predictive value. Protein expression is typically assigned a 'positive' score based on a predetermined cutoff. A semiquantitative scoring method that evaluates the percentage of positive tumor cells (0-100%) may provide a better understanding of the prognostic or predictive significance of these markers. The aim of this study was to assess and compare the interobserver agreement of immunohistochemistry scores using a percentage scoring method and three categorical scoring systems. Immunohistochemistry for p53, Bcl-2, vascular endothelial growth factor (VEGF) and apoptotic protease activating factor-1 (APAF-1) was performed on 87 tumor biopsies from patients with rectal carcinoma and scored independently by four pathologists as the percentage of positive tumor cells. Interobserver agreement was assessed by the intraclass correlation coefficient. The intraclass correlation coefficients for p53 and VEGF (>0.6) indicate substantial agreement between observers. The distribution of Bcl-2 and APAF-1 scores in addition to weaker interobserver agreement by percentage scoring suggest that this approach may not be appropriate for these proteins. In conclusion, p53 and VEGF protein expression assessed by immunohistochemistry in colorectal cancer and scored as a percentage of positive tumor cells may be a viable alternative scoring method.

AB - Molecular tumor markers are often studied in colorectal cancer using immunohistochemistry to determine their prognostic or predictive value. Protein expression is typically assigned a 'positive' score based on a predetermined cutoff. A semiquantitative scoring method that evaluates the percentage of positive tumor cells (0-100%) may provide a better understanding of the prognostic or predictive significance of these markers. The aim of this study was to assess and compare the interobserver agreement of immunohistochemistry scores using a percentage scoring method and three categorical scoring systems. Immunohistochemistry for p53, Bcl-2, vascular endothelial growth factor (VEGF) and apoptotic protease activating factor-1 (APAF-1) was performed on 87 tumor biopsies from patients with rectal carcinoma and scored independently by four pathologists as the percentage of positive tumor cells. Interobserver agreement was assessed by the intraclass correlation coefficient. The intraclass correlation coefficients for p53 and VEGF (>0.6) indicate substantial agreement between observers. The distribution of Bcl-2 and APAF-1 scores in addition to weaker interobserver agreement by percentage scoring suggest that this approach may not be appropriate for these proteins. In conclusion, p53 and VEGF protein expression assessed by immunohistochemistry in colorectal cancer and scored as a percentage of positive tumor cells may be a viable alternative scoring method.

KW - Immunohistochemistry

KW - Interobserver reliability

KW - p53

KW - Rectal cancer

KW - Scoring system

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=33747624927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747624927&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800642

DO - 10.1038/modpathol.3800642

M3 - Article

C2 - 16741523

AN - SCOPUS:33747624927

VL - 19

SP - 1236

EP - 1242

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 9

ER -